‘Jordan had no reports of AstraZeneca-related clots so far’

AMMAN — So far, there have been no reports of blood clotting incidents in recipients of the AstraZeneca vaccine in Jordan, Director General of the Food and Drug Administration Nizar Mheidat said on Wednesday.اضافة اعلان

Mheidat noted that all reports received in relation to the COVID-19 vaccines reported common and expected side effects, such as general fatigue, joint and muscle pain, shivers, fever, headache, and nausea, the Jordan News Agency, Petra, reported.

The director general added that the authority studies these reports thoroughly, and refers them to specialized technical committees, stressing that all administered vaccines have been subjected to clinical trials and have been proven to be safe, according to Petra.

Read more national news